PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Melatonin - Insomnia in adults
PAD Profile : Melatonin - Insomnia in adults
Brand Names Include :
Circadin
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
Type
Document
Review Date
Letter template (to patient)
Committee Recommendations
Date
Committee Name
Narrative
01 June 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey and North West Sussex Area Prescribing Committee (APC) recommends Melatonin (prescribed generically as 2mg modified release tablets) for the short term (up to 13 weeks) treatment of primary insomnia in patients aged 55 years or over.
The APC were supportive of switching patients from branded to generic 2mg modified release tablets.
Melatonin 2mg prolonged release tablets for this indication will be given a GREEN status on the traffic light system
Associated BNF Codes
04. Central Nervous System
04.01.01. Hypnotics